Pain, Chronic
Conditions
Brief summary
The purpose of this study is to verify the effectiveness and safety of transcranial direct current stimulation in patients with central post-stroke pain.
Interventions
DEVICETranscranial Direct Current Stimulation(tDCS)
The tDCS intervention was conducted for 20 minutes(2000μA) each time, 5 times a week for 2 weeks, a total of 10 times.
DEVICESham Transcranial Direct Current Stimulation(sham tDCS)
The sham tDCS intervention was conducted for 20 minutes(0μA) each time, 5 times a week for 2 weeks, a total of 10 times.
Sponsors
Pusan National University Yangsan Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
19 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
1. Adults aged 19 to 90 years old 2. Those who have been diagnosed with first-time stroke through doctors' clinical observation and brain imaging diagnosis 3. A person whose stroke lesions are cortex or subcortex 4. A person who satisfies 'Mandatory criteria' 5. Those with cognitive ability to understand and follow the researcher's instructions 6. Those who voluntarily agree to participate in this clinical trial and signed the agreement
Exclusion criteria
1. Those who have a fracture or have undergone orthopedic surgery 2. In case of accompanying serious neurological diseases 3. In case of major psychiatric diseases such as major depression disorders, schizophrenia, bipolar disorders, and dementia 4. Those with complex part pain syndrome by Budapest Criteria 5. If there is a cause of other pain in the relevant area, such as peripheral nerve damage 6. Persons included in the exclusion of transcranial direct current stimulation 7. If the researcher is judged to be judged that the participation in this study is not appropriate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of pain score in Brief Pain Inventory(BPI) | Baseline, after 2 weeks(after the end of intervention) | Brief Pain Inventory(BPI) is used for measurement. The Brief Pain Inventory (BPI) is a tool used to assess pain severity and its impact on daily functions. The BPI typically uses an 11-point numeric rating scale (NRS) for its pain severity and pain interference items. Each item is rated from 0 to 10. Pain Severity: 0 (no pain) to 10 (pain as bad as you can imagine). Pain Interference: 0 (does not interfere) to 10 (completely interferes). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of pain score in Neuropathic Pain Scale(NPS) | Baseline, after 2 weeks(after the end of intervention) | Neuropathic Pain Scale(NPS) is used for measurement. The Neuropathic Pain Scale (NPS) is a tool used to assess the various qualities and intensities of neuropathic pain. Each Item: 0 (no pain or absence of the described pain quality) to 10 (the most intense pain or presence of the described pain quality imaginable). |
| Change of depression score in Beck Depression Inventory-II(BDI-II) | Baseline, after 2 weeks(after the end of intervention) | Beck Depression Inventory-II(BDI-II) is used for measurement. The Beck Depression Inventory-II (BDI-II) is a widely used instrument for measuring the severity of depression. Minimum and Maximum Values: The BDI-II consists of 21 items, each rated on a 4-point scale ranging from 0 to 3. Total Score Range: 0 to 63. Each Item: 0 (symptom is absent) to 3 (severe level of the symptom). |
| Change of quality of life score in the EuroQol Five-dimensions-Three-Level Quality of Life Instrument(EQ-5D-3L) | Baseline, after 2 weeks(after the end of intervention) | The EuroQol Five-dimensions-Three-Level Quality of Life Instrument(EQ-5D-3L) is used for measurement. The EuroQol Five-Dimensions-Three-Level Quality of Life Instrument (EQ-5D-3L) is a standardized instrument used to measure health-related quality of life. This utility score reflects the overall quality of life associated with each health state and typically ranges from -0.594 to 1 in the UK: A value closer to 1 indicates a better health state. |
Countries
South Korea
Outcome results
None listed